Net Cash Provided by (Used in) Financing Activities in USD of CorMedix Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CorMedix Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • CorMedix Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $6.09M.
  • CorMedix Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $26.3M, a 52.9% decline from 2023.
  • CorMedix Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $55.9M, a 212% increase from 2022.
  • CorMedix Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $17.9M, a 57.1% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

CorMedix Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $6.09M +$6.19M 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025
Q1 2024 -$97.1K -$7.3M -101% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025
Q1 2023 $7.2M +$4.2M +140% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q1 2022 $3M -$38.6M -92.8% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q1 2021 $41.6M +$38.7M +1367% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q1 2020 $2.83M -$13.1M -82.2% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q1 2019 $16M +$12.7M +388% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q1 2018 $3.27M +$2.92M +823% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019
Q1 2017 $354K +$88.2K +33.2% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q1 2016 $266K -$6.56M -96.1% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q1 2015 $6.83M -$1.43M -17.3% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q1 2014 $8.25M +$7.78M +1638% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015
Q1 2013 $475K +$475K 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q1 2012 $0 01 Jan 2012 31 Mar 2012 10-Q/A 04 Mar 2014

CorMedix Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $26.3M -$29.6M -52.9% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025
2023 $55.9M +$38M +212% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025
2022 $17.9M -$23.9M -57.1% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024
2021 $41.8M +$1.66M +4.13% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 $40.1M +$14.3M +55.4% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022
2019 $25.8M -$3.59M -12.2% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021
2018 $29.4M +$8.87M +43.2% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020
2017 $20.5M +$13.4M +189% 01 Jan 2017 31 Dec 2017 10-K 29 May 2019
2016 $7.09M -$36.5M -83.7% 01 Jan 2016 31 Dec 2016 10-K 19 Mar 2018
2015 $43.6M +$35.3M +422% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2017
2014 $8.36M +$3.15M +60.6% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2017
2013 $5.2M +$4.08M +362% 01 Jan 2013 31 Dec 2013 10-K 12 Mar 2015
2012 $1.13M +$1.13M 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014
2011 $0 -$10.5M -100% 01 Jan 2011 31 Dec 2011 10-K 27 Mar 2013
2010 $10.5M 01 Jan 2010 31 Dec 2010 10-K/A 26 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.